NIOSH Exploratory/Developmental Grant Program (R21)
ID: 305594Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$0 - $200K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering the NIOSH Exploratory/Developmental Grant Program (R21) to support innovative research aimed at understanding and mitigating risks associated with occupational diseases and injuries. This grant program encourages applicants to develop projects that identify hazardous working conditions, create preventive measures, and translate scientific findings into effective workplace practices, aligning with the strategic goals of the National Occupational Research Agenda (NORA). The program emphasizes collaboration and the dissemination of research findings, with a total estimated funding of $1 million and an award ceiling of $200,000 for individual projects over a two-year period. Interested applicants must submit their proposals by November 17, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further assistance.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), has issued the NIOSH Exploratory/Developmental Grant Program (R21) Funding Opportunity Announcement (FOA) aimed at advancing research in occupational safety and health. This program is intended to support innovative projects that identify risks associated with occupational diseases and injuries, develop preventive measures, and translate findings into effective workplace practices. Key objectives include identifying hazardous working conditions, creating new protective technologies, and assessing the economic impacts of occupational health issues. The FOA encourages diverse applicants, including educational institutions and nonprofit organizations, to explore novel research approaches while addressing specific burdens in occupational health. Successful applications should align with the strategic goals of NIOSH, particularly in light of the National Occupational Research Agenda (NORA). The funding allows up to $275,000 in direct costs over a two-year period, with an emphasis on collaboration and effective dissemination of research findings. The program underlines the importance of scientific innovation to reduce worker exposure to hazards and improve overall public health outcomes.
    Similar Opportunities
    NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a grant opportunity titled "NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)" aimed at supporting high-quality scientific meetings that advance research in occupational safety and health. Eligible applicants, including nonprofits without 501(c)(3) status and higher education institutions, are encouraged to submit proposals that align with NIOSH's strategic goals and the National Occupational Research Agenda (NORA), focusing on significant occupational health issues. This initiative underscores NIOSH's commitment to enhancing workplace safety through rigorous research and collaboration among experts, with a total funding amount of $500,000 available for up to five awards, each ranging from $10,000 to $20,000. Interested parties should submit their applications by December 15, 2025, and can contact Sharon Chou, Ph.D., at SChiou@cdc.gov for further information.
    Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering exploratory and developmental grants related to the World Trade Center Health Program (R21) to support research addressing diagnostic and treatment uncertainties for individuals affected by the 9/11 attacks. This funding opportunity aims to encourage innovative research projects that explore new areas of investigation, potentially leading to significant advancements in treatment effectiveness and diagnostic practices for those receiving monitoring and treatment under the James Zadroga 9/11 Health and Compensation Act. With an estimated total program funding of $30 million and an expected 60 awards, applicants can request funding ranging from $0 to $365,000. Interested parties should note that applications are due by 5:00 PM local time on February 12, 2026, and can direct inquiries to Dr. Eduardo O'Neill at 404-718-8844 or via email at fzt4@cdc.gov.
    National Center for Construction Safety and Health Research and Translation (U54)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the National Center for Construction Safety and Health Research and Translation (U54), aimed at reducing work-related injuries and illnesses in the construction industry. This funding opportunity encourages multidisciplinary research and intervention strategies that focus on hazard identification, the development of safety practices, and the dissemination of best practices to enhance the health and safety of U.S. construction workers. The initiative aligns with national public health goals, including the Healthy People 2030 objectives, and emphasizes collaboration with various stakeholders to address significant health burdens in the construction workforce. The total funding available is approximately $28.75 million over five years, with individual awards capped at $5.75 million per budget year. Interested applicants must submit a Letter of Intent by November 1, 2023, and complete applications by December 1, 2023, with subsequent deadlines on October 31 in the following years until 2026. For further inquiries, applicants can contact Sharon Chiou at 304-285-6029 or via email at schiou@cdc.gov.
    Research Grants for Preventing Violence and Violence Related Injury (R01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering research grants aimed at preventing violence and violence-related injuries through the initiative titled "Research Grants for Preventing Violence and Violence Related Injury (R01)." This program seeks to fund effectiveness research that evaluates innovative programs, practices, or policies designed to address interpersonal violence and suicide, particularly among youth and young adults aged 10 to 24 years. With an estimated total program funding of $9.6 million, the CDC anticipates awarding approximately eight grants, with individual awards ranging from $0 to $400,000. Interested applicants can reach out to Samantha Case at ncipcerpo@cdc.gov or by phone at 907-271-1569, with applications due by December 1, 2025, and project start dates expected around September 30, 2026.
    State Occupational Safety and Health Surveillance Program (U60)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for the State Occupational Safety and Health Surveillance Program (U60), aimed at enhancing state-level surveillance of workplace safety and health issues. This cooperative agreement seeks to assess the extent of workplace illnesses, injuries, and fatalities, identify high-risk occupations, and develop effective prevention strategies through a network of partnerships and data-driven initiatives. With an estimated total program funding of $40 million and an award ceiling of $705,000, the CDC anticipates making approximately 23 awards, with applications due by September 30, 2025. Interested applicants can reach out to Dr. Eduardo O'Neill at 404-718-8844 or via email at fzt4@cdc.gov for further information.
    Grants to Support New Investigators in Conducting Research Related to Preventing Interpersonal Violence Impacting Children and Youth
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering grants to support new investigators in conducting research aimed at preventing interpersonal violence impacting children and youth. Applicants are required to propose research projects that align with specific NCIPC research priorities, including adverse childhood experiences, child abuse and neglect, youth violence, intimate partner violence, sexual violence, and suicide, focusing on individuals aged birth to 17 years. This funding opportunity, with an estimated total program funding of $1.8 million and an award ceiling of $150,000, is designed to foster the development of independent researchers in the field of violence prevention. Interested applicants should note that the application deadline is December 1, 2025, and can reach out to Tamara N. Crawford at ncipcerpo@cdc.gov for further information.
    Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity through the Commercial Fishing Occupational Safety Research Cooperative Agreement (U01) aimed at enhancing the safety of workers in the commercial fishing industry. This initiative seeks to support research that addresses various aspects of occupational safety, including vessel design improvements, emergency equipment development, and enhanced monitoring systems, targeting entities with expertise in fishing and maritime safety. With an estimated total program funding of $3 million and awards ranging from $150,000 to $975,000, the CDC anticipates making approximately 20 awards. Interested applicants must submit their proposals electronically by 5:00 PM ET on January 31, 2028, and can direct inquiries to Bridgette Garrett at bgarrett@cdc.gov.
    Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering a Small Business Innovation Research (SBIR) Grant opportunity for United States small business concerns (SBCs) to submit applications for various phases of research and development, including Phase I, Phase II, Direct to Phase II, Fast-Track, and Phase IIB grants. Eligible applicants must possess the necessary research capabilities and technological expertise to support the R&D missions of the NIH and CDC, with a focus on health-related innovations. This funding opportunity is significant as it encourages collaboration among small businesses to advance health research, with applications expected to be solicited following the reauthorization of the SBIR program. Interested parties can reach out to the NIH SEED Office at SEEDinfo@nih.gov or call 301-827-8595 for further information, with the estimated synopsis posting date set for October 1, 2025, and a closing date for applications anticipated on January 5, 2026.